Objective To compare the effects and side effects of paclitaxel liposome formula on advanced non-small cell lung cancer(NSCLC),as a 3-hour non-stop infusion.Methods Fifty-four advanced NSCLC patients were randomized into two group.The traditional taxol group(control group,n=18) was administered the premedications which was used routinely for the prevention of hypersensitivity reactions.The paclitaxel liposome group(study group,n=36) received a 3-hour non-stop infusion.Results The overall response rate of both groups was 39%.There was no significant difference between the two groups(P≥0.05).There was no significant difference in roution toxicity between the two groups(P≥0.05).The toxicity from the mixed solvent of polyethoxylated castor oil and ethanol was significantly lower in the study group than in the control group(P≤0.05).Conclusion Paclitaxel liposome is effective in the treatment of NSCLC via intravenous infusion.It does not contain cremophor EL.It has less side effects.Even if there are side effects,they are tolerable